Keros Therapeutics Inc (KROS) — Cash Flow Quality Index

Latest as of March 2025: 1.09x

Keros Therapeutics Inc (KROS) has a Cash Flow Quality Index of 1.09x as of March 2025. Operating cash flow of $161.17 Million exceeds net income of $148.45 Million, indicating high earnings quality where cash backs reported profits. Also explore Keros Therapeutics Inc asset portfolio for the complete picture of this company's asset base.

Cash Flow Quality Index

1.09x

Operating CF / Net Income

Operating Cash Flow

$161.17 Million

USD

Net Income

$148.45 Million

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Keros Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Keros Therapeutics Inc. For live market cap and the full company financial profile, see Keros Therapeutics Inc (KROS) total market value.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.